A co-inhibitory molecule, B7-H4, synergistically potentiates oral tolerance by inducing CD4+CD25+FoxP3+ T cells
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: A co-inhibitory molecule, B7-H4, is believed to negatively regulate T cell immunity by suppressing T cell proliferation and inhibiting cytokine production. However, the mechanism behind B7-H4-mediated tolerance remains unclear. Methods: Balb/c (H-2d) mice were fed with dendritic cell line, DC2.4 (H-2b) every day for 10 days. Meantime, mice were hydrodynamically injected with recombinant plasmid expressing B7-H4 fusion protein (B7-H4.hFc) or hFc via tail vein. One day after last feeding, mice were immunized with allogeneic B6 spleen cells. 14 days following immunization, mice were challenged with B6 spleen cells to ear back and the ear swelling was determined the next day. Subsequently, a mixed lymphocyte reaction (MLR) was also performed and cytokines profiles from the reaction were examined by sandwich ELISA. Frequency of immunosuppressive cell population was assayed with flow cytometry and mRNA for FoxP3 was determined by RT-PCR. Results: Tolerant mice given plasmid expressing B7-H4.hFc showed a significant reduction in ear swelling compared to control mice. In addition, T cells from mice given B7-H4.hFc plasmid revealed a significant hyporesponsiveness of T cells against allogeneic spleen cells and showed a significant decrease in Th1 and Th2 cytokines such as IFN-γ, IL-5, and TNF-α. Interestingly, flow cytometric analysis showed that the frequency of CD4+CD25+FoxP3+ Tregs in spleen was increased in tolerant mice given recombinant B7-H4.hFc plasmid compared to control group. Conclusion: Our results demonstrate that B7-H4 synergistically potentiates oral tolerance induced by allogeneic cells by increasing the frequency of FoxP3+CD4+CD25+ Treg and reducing Th1 and Th2 cytokine production.
Abstract
Background: A co-inhibitory molecule, B7-H4, is believed to negatively regulate T cell immunity by suppressing T cell proliferation and inhibiting cytokine production. However, the mechanism behind B7-H4-mediated tolerance remains unclear. Methods: Balb/c (H-2d) mice were fed with dendritic cell line, DC2.4 (H-2b) every day for 10 days. Meantime, mice were hydrodynamically injected with recombinant plasmid expressing B7-H4 fusion protein (B7-H4.hFc) or hFc via tail vein. One day after last feeding, mice were immunized with allogeneic B6 spleen cells. 14 days following immunization, mice were challenged with B6 spleen cells to ear back and the ear swelling was determined the next day. Subsequently, a mixed lymphocyte reaction (MLR) was also performed and cytokines profiles from the reaction were examined by sandwich ELISA. Frequency of immunosuppressive cell population was assayed with flow cytometry and mRNA for FoxP3 was determined by RT-PCR. Results: Tolerant mice given plasmid expressing B7-H4.hFc showed a significant reduction in ear swelling compared to control mice. In addition, T cells from mice given B7-H4.hFc plasmid revealed a significant hyporesponsiveness of T cells against allogeneic spleen cells and showed a significant decrease in Th1 and Th2 cytokines such as IFN-γ, IL-5, and TNF-α. Interestingly, flow cytometric analysis showed that the frequency of CD4+CD25+FoxP3+ Tregs in spleen was increased in tolerant mice given recombinant B7-H4.hFc plasmid compared to control group. Conclusion: Our results demonstrate that B7-H4 synergistically potentiates oral tolerance induced by allogeneic cells by increasing the frequency of FoxP3+CD4+CD25+ Treg and reducing Th1 and Th2 cytokine production.
참고문헌 (25)
- Greenwald RJ, "The B7 family revisited", Annu Rev Immunol, 23, pp.515~548 (2005)
- Subudhi SK, "The balance of immune responses: costimulation verse coinhibition", J Mol Med, 83, pp.193~202 (2005)
- Martin-Orozco N, "New battlefields for costimulation", J Exp Med, 203, pp.817~820 (2006)
- Keir ME, "The B7", CD28 costimulatory family in autoimmunity, 2005, pp.204, 128~143
- Grohmann UC, "CTLA-4-Ig regulates tryptophan catabolism in vivo", Nat Immunol, 3, pp.1097~1101 (2002)
- Boasso A, "Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells", Blood, 105, pp.1574~1581 (2005)
- Suh WK, "Generation and characterization of B7-H4", B7S1, Mol Cell Biol, pp.2006, 26[DOI]
- Kryczek I, "Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells", J Immunol, 177, pp.40~44 (2006)
- Kryczek I, "B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma", J Exp Med, 203, pp.871~881 (2006)
- Mowat AM, "Oral tolerance: overview and historical perspectives", Ann N Y Acad Sci, 1029, pp.1~8 (2004)
- Niederkorn JY, "Phenotypic analysis of oral tolerance to alloantigens: evidence that the indirect pathway of antigen presentation is involved", Transplantation, 73, pp.1493~1500 (2002)
- Zelenika D, "Rejection of H-Y disparate skin grafts by monospecific CD4+ Th1 and Th2 cells: no requirement for CD8+ T cells or B cells", J Immunol, 161, pp.1868~1874 (1998)
- Barber DL, "Restoring function in exhausted CD8 T cells during chronic viral infection", Nature, 439, pp.682~687 (2006)
- Dong H, "B7-H1 pathway and its role in the evasion of tumor immunity", J Mol Med, 81, pp.281~287 (2003)
- Friedman A, "Induction of anergy or active suppression following oral tolerance is determined by antigen dosage", Proc Natl Acad Sci U S A, 91, pp.6688~6692 (1994)
- Miller A, "Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering", Proc Natl Acad Sci U S A, 89, pp.421~425 (1992)
- Melamed D, "Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin", Eur J Immunol, 23, pp.935~942 (1993)
- Guillonneau C, "CD40Ig treatment results in allograft acceptance mediated by CD8CD-45RC T cells, IFN-gamma, and indoleamine 2,3-dioxygenase", J Clin Invest, 117, pp.1096~1106 (2007)
- He XY, "IL-5 prolongs allograft survival by downregulating IL-2 and IFN-gamma cytokines", Transplant Proc, 33, pp.703~704 (2005)
- Min SY, "Antigen-induced, tolerogenic CD11c+,CD11b+ dendritic cells are abundant in Peyer's patches during the induction of oral tolerance to type II collagen and suppress experimental collagen-induced arthritis", Arthritis Rheum, 54, pp.887~898 (2006)
- Kim HJ, "NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor beta, and by clonally deleting antigen-specific T cells", Immunology, 118, pp.101~111 (2006)
- Joffre O, "Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes", Nat Med, 14, pp.88~92 (2008)
- Dubruel P, "Vinyl polymers as non-viral gene delivery carriers: current status and prospects", Macromol Biosci, 6, pp.89~810 (2006)
- Li W, "Lipid-based nanoparticles for nucleic acid delivery", Pharm Res, 24, pp.438~449 (2007)
- Subudhi S K, "Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection", J Clin Invest, 113, pp.694~700 (2004)